Robert J Mentz1, James A Tulsky2, Bradi B Granger3, Kevin J Anstrom4, Patricia A Adams5, Gwen C Dodson2, Mona Fiuzat4, Kimberly S Johnson2, Chetan B Patel5, Karen E Steinhauser6, Donald H Taylor7, Christopher M O'Connor5, Joseph G Rogers5. 1. Division of Cardiology, Duke University Medical Center, Durham, NC. Electronic address: Robert.mentz@duke.edu. 2. Division of General Medicine (Palliative Medicine Section), Duke University Medical Center, Durham, NC. 3. Duke University School of Nursing, Duke University Medical Center, Durham, NC. 4. Duke Clinical Research Institute, Durham, NC. 5. Division of Cardiology, Duke University Medical Center, Durham, NC. 6. Department of Medicine, Duke University Medical Center, Durham, NC; Center for Health Services Research in Primary Care, Durham VA Medical Center, Durham, NC. 7. Duke Sanford School of Public Policy, Durham, NC.
Abstract
BACKGROUND: The progressive nature of heart failure (HF) coupled with high mortality and poor quality of life mandates greater attention to palliative care as a routine component of advanced HF management. Limited evidence exists from randomized, controlled trials supporting the use of interdisciplinary palliative care in HF. METHODS: PAL-HF is a prospective, controlled, unblinded, single-center study of an interdisciplinary palliative care intervention in 200 patients with advanced HF estimated to have a high likelihood of mortality or rehospitalization in the ensuing 6 months. The 6-month PAL-HF intervention focuses on physical and psychosocial symptom relief, attention to spiritual concerns, and advanced care planning. The primary end point is health-related quality of life measured by the Kansas City Cardiomyopathy Questionnaire and the Functional Assessment of Chronic Illness Therapy with Palliative Care Subscale score at 6 months. Secondary end points include changes in anxiety/depression, spiritual well-being, caregiver satisfaction, cost and resource utilization, and a composite of death, HF hospitalization, and quality of life. CONCLUSIONS: PAL-HF is a randomized, controlled clinical trial that will help evaluate the efficacy and cost effectiveness of palliative care in advanced HF using a patient-centered outcome as well as clinical and economic end points.
RCT Entities:
BACKGROUND: The progressive nature of heart failure (HF) coupled with high mortality and poor quality of life mandates greater attention to palliative care as a routine component of advanced HF management. Limited evidence exists from randomized, controlled trials supporting the use of interdisciplinary palliative care in HF. METHODS:PAL-HF is a prospective, controlled, unblinded, single-center study of an interdisciplinary palliative care intervention in 200 patients with advanced HF estimated to have a high likelihood of mortality or rehospitalization in the ensuing 6 months. The 6-month PAL-HF intervention focuses on physical and psychosocial symptom relief, attention to spiritual concerns, and advanced care planning. The primary end point is health-related quality of life measured by the Kansas City Cardiomyopathy Questionnaire and the Functional Assessment of Chronic Illness Therapy with Palliative Care Subscale score at 6 months. Secondary end points include changes in anxiety/depression, spiritual well-being, caregiver satisfaction, cost and resource utilization, and a composite of death, HF hospitalization, and quality of life. CONCLUSIONS:PAL-HF is a randomized, controlled clinical trial that will help evaluate the efficacy and cost effectiveness of palliative care in advanced HF using a patient-centered outcome as well as clinical and economic end points.
Authors: Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; David Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Graham Nichol; Nina P Paynter; Pamela J Schreiner; Paul D Sorlie; Joel Stein; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner Journal: Circulation Date: 2013-01-01 Impact factor: 29.690
Authors: Ernst R Schwarz; Afshan Baraghoush; Ryan P Morrissey; Ankit B Shah; Arvind M Shinde; Anita Phan; Parag Bharadwaj Journal: J Palliat Med Date: 2012-01-04 Impact factor: 2.947
Authors: Joseph G Rogers; Chetan B Patel; Robert J Mentz; Bradi B Granger; Karen E Steinhauser; Mona Fiuzat; Patricia A Adams; Adam Speck; Kimberly S Johnson; Arun Krishnamoorthy; Hongqiu Yang; Kevin J Anstrom; Gwen C Dodson; Donald H Taylor; Jerry L Kirchner; Daniel B Mark; Christopher M O'Connor; James A Tulsky Journal: J Am Coll Cardiol Date: 2017-07-18 Impact factor: 24.094
Authors: Hillary D Lum; Evan P Carey; Diane Fairclough; Mary E Plomondon; Evelyn Hutt; John S Rumsfeld; David B Bekelman Journal: J Pain Symptom Manage Date: 2016-02-26 Impact factor: 3.612
Authors: Nancy Luo; Joseph G Rogers; Gwen C Dodson; Chetan B Patel; Anthony N Galanos; Carmelo A Milano; Christopher M O'Connor; Robert J Mentz Journal: Am J Cardiol Date: 2016-06-21 Impact factor: 2.778
Authors: Yuchieh Kathryn Chang; Holland Kaplan; Yimin Geng; Li Mo; Jennifer Philip; Anna Collins; Larry A Allen; John A McClung; Martin A Denvir; David Hui Journal: Circ Heart Fail Date: 2020-09-09 Impact factor: 8.790
Authors: Laura P Gelfman; Marie Bakitas; Lynne Warner Stevenson; James N Kirkpatrick; Nathan E Goldstein Journal: J Palliat Med Date: 2017-05-12 Impact factor: 2.947
Authors: Rachel S Tobin; Marc D Samsky; Maragatha Kuchibhatla; Christopher M O'Connor; Mona Fiuzat; Haider J Warraich; Kevin J Anstrom; Bradi B Granger; Daniel B Mark; James A Tulsky; Joseph G Rogers; Robert J Mentz; Kimberly S Johnson Journal: J Palliat Med Date: 2021-12-01 Impact factor: 2.947
Authors: Lauren K Truby; Christopher O'Connor; Mona Fiuzat; Amanda Stebbins; Adrian Coles; Chetan B Patel; Bradi Granger; Neha Pagidipati; Richa Agarwal; Jennifer Rymer; Angela Lowenstern; Pamela S Douglas; James Tulsky; Joseph G Rogers; Robert J Mentz Journal: Circ Heart Fail Date: 2020-04-09 Impact factor: 8.790